The structure of human cathepsin K, a potential target for treatment of osteoporosis, reveals active site differences with homologous cysteine proteinases that should enable the design of cathepsin K selective inhibitors.
- Baoguang Zhao
- Cheryl A. Janson
- Sherin S. Abdel-Meguid